AI assistant
INCYTE CORP — Director's Dealing 2022
Jan 5, 2022
30371_dirs_2022-01-05_d17146f7-2f3a-49ae-a478-5e03ccdfb28c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2022-01-01
Reporting Person: SWAIN PAULA J (EVP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-01 | Common Stock | A | 8678 | $0.00 | Acquired | 72371 | Direct |
| 2022-01-04 | Common Stock | M | 9319 | $73.21 | Acquired | 81690 | Direct |
| 2022-01-04 | Common Stock | S | 9319 | $73.46 | Disposed | 72371 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | Non Qualfied Stock Option (right to buy) | $73.21 | M | 9319 | Disposed | 2022-01-07 | Common Stock (9319) | Direct |
Footnotes
F1: Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Paula Swain's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
F3: Represents weighted average sale price. Actual sale prices ranged from $73.31 - $73.73. Reporting person undertakes to provide upon request
by Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of
shares sold within range indicated.
F4: Includes an aggregate of 33,663 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
F5: Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.